Although we were not able to identify sPD-L1 as an independent biomarker for survival, Fukuda et al. and Larrinaga et al. reported sPD-L1 as an independent biomarker for shorter overall survival and shorter 5-year overall survival for RCC patients [26,27]. The gene discussed is SPDL1; the disease is renal cell carcinoma.